These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8651034)

  • 1. The use of DAV (DTIC, ACNU and VCR) and natural interferon-beta combination therapy in malignant melanoma.
    Nagatani T; Ichiyama S; Onuma R; Miyazawa M; Matsuzaki T; Miyagawa K; Baba N; Uchiyama M; Nakajima H
    Acta Derm Venereol; 1995 Nov; 75(6):494. PubMed ID: 8651034
    [No Abstract]   [Full Text] [Related]  

  • 2. Changes in immunological parameters after combination adjuvant therapy with intravenous DTIC, ACNU, and VCR, and local injection of IFN-beta (DAV + IFN-beta therapy) into malignant melanoma.
    Umeda T; Aoki K; Yokoyama A; Ohara H; Hayashi O; Tanaka K; Nishioka K
    J Dermatol; 1998 Sep; 25(9):569-72. PubMed ID: 9798342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Local injection of interferon beta in malignant melanoma of the esophagus as adjuvant of systemic pre- and postoperative DAV chemotherapy: case report with 7 years of long-term survival.
    Kawada K; Kawano T; Nagai K; Nishikage T; Nakajima Y; Tokairin Y; Ogiya K; Tanaka K; Iwai T
    Gastrointest Endosc; 2007 Aug; 66(2):408-10. PubMed ID: 17643724
    [No Abstract]   [Full Text] [Related]  

  • 4. Two cases of malignant melanoma of the toe developed skin ulcers following local injection of natural beta-interferon.
    Kurashige Y; Irisawa R; Abe N; Saito M; Tsuboi R
    J Dermatol; 2012 Dec; 39(12):1037-8. PubMed ID: 22758215
    [No Abstract]   [Full Text] [Related]  

  • 5. Complete remission of metastatic clear cell sarcoma with DAV chemotherapy.
    Fujimoto M; Hiraga M; Kiyosawa T; Murakami T; Murata S; Ohtsuki M; Nakagawa H
    Clin Exp Dermatol; 2003 Jan; 28(1):22-4. PubMed ID: 12558622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Malignant melanoma in Japan: unique distribution and effect of DAV chemoimmunotherapy (part II)].
    Ishihara K; Hayasaka K; Ikeda S; Terakado T; Kukita A; Seki Y; Jimbow K; Suzuki M
    Gan To Kagaku Ryoho; 1984 Mar; 11(3):467-73. PubMed ID: 6703721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A case report of anorectal malignant melanoma showing a complete response after DTIC/ACNU/VCR therapy].
    Sasaki S; Kojima T; Hidemura A; Hatanaka K; Uekusa T; Ishimaru M
    Gan To Kagaku Ryoho; 2010 Oct; 37(10):1999-2002. PubMed ID: 20948273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chemotherapy of malignant melanoma].
    Ishihara K; Yamazaki N; Asano K
    Gan To Kagaku Ryoho; 1993 Aug; 20(10):1287-92. PubMed ID: 7688498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Control of multiple skin and lung metastasis of malignant melanoma by combined DAV and OK-432 chemoimmunotherapy in association with large-scale administration of indomethacin].
    Maeda K; Miura S; Kawamura M; Jimbow K
    Gan To Kagaku Ryoho; 1984 Nov; 11(11):2434-7. PubMed ID: 6497401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New combination chemotherapy for malignant melanoma--PAV(peplomycin, ACNU, VCR) therapy].
    Ikeda S; Tajima K; Miyasato H; Terakado T; Suzuki T; Miura T
    Gan To Kagaku Ryoho; 1983 Oct; 10(10):2198-204. PubMed ID: 6194756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chemotherapy of malignant melanoma].
    Ishihara K
    Gan To Kagaku Ryoho; 1995 Jan; 22(1):23-7. PubMed ID: 7529980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Malignant melanoma in Japan: unique distribution and effect of DAV chemoimmunotherapy].
    Jimbow K; Takahashi H; Ishihara K; Hayasaka K; Kukita A; Seki Y; Ikeda S; Terakado T
    Gan To Kagaku Ryoho; 1982 Nov; 9(11):1942-9. PubMed ID: 7184382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary malignant melanoma of the esophagus treated by esophagectomy and systemic chemotherapy.
    Matsutani T; Onda M; Miyashita M; Hagiwara N; Akiya Y; Takubo K; Yamashita K; Sasajima K
    Dis Esophagus; 2001; 14(3-4):241-4. PubMed ID: 11869329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon-alpha induced mania during the adjuvant treatment of malignant melanoma.
    Ni Mhaolain AM; Thakore JH
    Ir J Med Sci; 2007; 176(2):137-9. PubMed ID: 17394037
    [No Abstract]   [Full Text] [Related]  

  • 15. [Case of metastatic malignant melanoma responded to combination chemotherapy with DTIC].
    Tamura T; Miyamoto H; Harada M; Makinoya T; Yamamoto M; Miyoshi Y; Komi N
    Gan To Kagaku Ryoho; 1984 Feb; 11(2):327-32. PubMed ID: 6582806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Metastatic malignant melanoma of the urinary bladder: a case report].
    Nohara T; Sakai A; Fuse H; Imamura Y
    Nihon Hinyokika Gakkai Zasshi; 2009 Nov; 100(7):707-11. PubMed ID: 19999137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myelodysplastic syndrome following treatment of malignant melanoma with vincristine, ACNU, and dacarbazine.
    Kageshita T; Kuribayashi N; Ono T
    J Dermatol; 2000 Mar; 27(3):178-80. PubMed ID: 10774145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant melanoma treated with natural interferons alfa and beta and DAV.
    Nagatani T; Ichiyama S; Miyakawa K; Uchiyama M
    Eur J Cancer; 1992; 28A(10):1774. PubMed ID: 1389506
    [No Abstract]   [Full Text] [Related]  

  • 19. Therapy-related myelodysplastic syndrome developed by dacarbazine, nimustine hydrochloride and vincristine sulfate (DAV) therapy for patient with malignant melanoma.
    Nitta Y; Ikeya T; Sakakibara A; Tomita Y
    J Dermatol; 2011 Feb; 38(2):164-8. PubMed ID: 21269313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amelanotic malignant melanoma of the esophagus: report of a patient with recurrence successfully treated with chemoendocrine therapy.
    Suzuki Y; Aoyama N; Minamide J; Takata K; Ogata T
    Int J Clin Oncol; 2005 Jun; 10(3):204-7. PubMed ID: 15990972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.